Your Location:
Home >
Browse articles >
Regulation of Alzheimer's Disease by Chinese Medicine Based on BDNF/TrkB Signaling Pathway: A Review
Regulation of Alzheimer's Disease by Chinese Medicine Based on BDNF/TrkB Signaling Pathway: A Review
Enhanced Publication- Chinese Journal of Experimental Traditional Medical Formulae Vol. 30, Issue 20, Pages: 274-282(2024)
DOI: 10.13422/j.cnki.syfjx.20240719
Scan QR Code
AI Introduction
Full Text(HTML)
References
Publication Info
Metrics
393
Views
807
Downloads
2
CSCD
Alert me when the article has been cited
Submit
Tools
- BibTeXDownload
- EndnoteDownload
- RefMan Download
- NoteExpressDownload
- NoteFirstDownload
Related Articles
Danggui Shaoyaosan Alleviates Cognitive Impairment by Regulating Ketone Body Metabolism and Glutamate/AMPAR Pathway
Mechanisms of Shangxia Liangji Danin Improving Cognitive Function in AD Mice Based on PI3K/Akt Signaling Pathway
Mechanisms of Action of Angelica sinensis in Prevention and Treatment of Alzheimer's Disease: A Review
Si Junzitang Ameliorates Alzheimer's Disease by Regulating Keap1/Nrf2/HO-1 Signaling Pathway
Mechanism of Xixintang in Protecting Blood-brain Barrier in Alzheimer's Disease Model Rats Based on AQP4 Polarization
Related Author
SUN Shibiao
PAN Xiaolong
WEI Zhihui
LIU Feixiang
ZHANG Yunke
WANG Shasha
WANG Xin
GONG Kexin
Related Institution
Henan University of Chinese Medicine
The First Affiliated Hospital of Henan University of Chinese Medicine
Science and Technology Innovation Center, Guangzhou University of Chinese Medicine
Zhongshan Hospital of Traditional Chinese Medicine Affiliated to Guangzhou University of Chinese Medicine
Hubei University of Chinese Medicine


